Conference Coverage
Conference Coverage
Routine COVID-19 screening unnecessary for cancer outpatients
Conference Coverage
Influenza-related maternal morbidity has more than doubled over 15 years
“The findings suggest that influenza may either be a contributor to rising rates of severe maternal morbidity or synergistically amplifying...
Conference Coverage
Racial/ethnic disparities in cesarean rates increase with greater maternal education
While the likelihood of a cesarean delivery usually drops as maternal education level increases, the disparities seen in cesarean rates between...
Conference Coverage
Romosozumab may not increase cardiovascular risk after all
Could a cardioprotective effect of bisphosphonates in a pivotal clinical trial of romosozumab explain why the biologic was given a black-box...
Conference Coverage
Consider home subcutaneous immune globulin for refractory dermatomyositis
Patients prefer home subQ over IVIg, citing greater feeling of autonomy.
Latest News
PPE protected critical care staff from COVID-19 transmission
Staff acquisition peaked 3 weeks before the peak of COVID-19 ICU admission.
Conference Coverage
Vedolizumab looks safer than anti-TNF drugs in older adults with IBD
An analysis of a Medicare claims database finds vedolizumab is associated with efficacy similar to that of anti-TNF inhibitors, with fewer...
Conference Coverage
Women and ACS: Focus on typical symptoms to improve outcomes
Strict guideline adherence could reverse the poorer acute coronary syndrome outcomes in women. Chest pain “is pretty much equal between men and...
Conference Coverage
Psychiatrist recounts haunting ordeal with an anonymous stalker
Dr. William J. Newman said he wrote farewell notes to his wife, children, and loved ones, “just in case.”
Conference Coverage
Expert calls for paradigm shift in lab monitoring of some dermatology drugs
A patient’s propensity for developing drug-induced liver injury from terbinafine use is not predictable from LFT monitoring, according to Dr....
Conference Coverage
Molecular insights suggest novel therapies for hidradenitis suppurativa
Many key molecular pathways involved in HS pathogenesis can be targeted by commercially available agents having other indications.